 I'm Deborah Borchardt and this is your Marijuana Money Minute. You've probably seen on the news all the fires out in California. We're hearing that there are some cannabis forms that were destroyed in those fires. We want you to know that we're thinking of you and our hearts go out to you. This week, Pennsylvania Democratic Governor Tom Wolf said that regulating adult use cannabis and restoring justice to those with past marijuana convictions were among his fall legislative priorities. So big news out of Pennsylvania. Columbia Care said it's planning on buying the green solution out of Colorado. This company has unaudited revenues due July 2020 of 52.7 million dollars and Columbia Care says the deal will be immediately accretive. My men said that it is going to do a study on MDMA and LSD at the University Hospital in Basil. The idea is that they're going to do a phase one trial that will begin in the fourth quarter to look at whether MDMA will reduce the potential of a bad trip if you're having an LSD medical treatment. We have a lot of earnings to go over this week, so we're just going to hit the highlights here. Tiltolding said that its revenue fell 9% to $38.6 million sequentially and the company blamed COVID-related headwinds on that. They said that there were decreased sales at their vape company Jupiter Research. They also said that there was a decline in some of the wholesale business because of the suspension of adult use cannabis sales in Massachusetts. Vario Health reported that their revenue went up. Now if you look at the revenue with the discontinued operations it was $12 million. If you take out those discontinued operations it was $10.8 million but that's still an increase of 59%. Now their net losses did go to $8.9 million, so that was versus a net loss of $1.8 million in the 2019 second quarter. The Canadian-based interspirit holdings, which is known for their chain called spirit leaf, reported that they had system-wide retail sales of $20.5 million. That was an increase of 343% and that's over $4.6 million in the second quarter in 2019. Hollister Biosciences reported that their revenue was $8.47 million in the second quarter. That's versus just $0.2 million for the same time period last year. The company attributed the revenue growth to the sale of concentrates, pre-rolls and contract manufacturing services. AIR Strategies said that their revenue fell 16% to $28 million in the second quarter from $33 million. The company also reported a net loss of $7.5 million. This is a little worse than the previous quarter's net income of $1.6 million. That's it for this week. I'm Deborah Borchart with the Green Market Report.